CATALOGO DEI PRODOTTI DELLA RICERCA

AMBROSETTI, Achille
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.467
EU - Europa 5.986
AS - Asia 1.762
SA - Sud America 23
AF - Africa 19
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 9
Totale 14.284
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.454
GB - Regno Unito 2.520
CN - Cina 1.533
DE - Germania 639
SE - Svezia 600
IT - Italia 567
FR - Francia 487
IE - Irlanda 414
FI - Finlandia 377
UA - Ucraina 155
RU - Federazione Russa 116
VN - Vietnam 76
TR - Turchia 39
BE - Belgio 37
IR - Iran 28
IN - India 25
KR - Corea 20
AU - Australia 17
BR - Brasile 12
RO - Romania 12
CA - Canada 11
CZ - Repubblica Ceca 11
EU - Europa 9
JP - Giappone 9
NL - Olanda 9
HK - Hong Kong 8
GH - Ghana 7
PL - Polonia 6
AT - Austria 5
CH - Svizzera 5
NP - Nepal 5
SG - Singapore 5
CL - Cile 4
ET - Etiopia 4
LV - Lettonia 4
AL - Albania 3
ES - Italia 3
ID - Indonesia 3
PE - Perù 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CM - Camerun 2
CO - Colombia 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
SI - Slovenia 1
SM - San Marino 1
UG - Uganda 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 14.284
Salva come PNG Salva come JPEG
Città #
Southend 2.234
Jacksonville 1.282
Chandler 1.029
Woodbridge 823
Ann Arbor 540
Dublin 414
Houston 355
Ashburn 316
Wilmington 215
Beijing 200
Jinan 190
Lawrence 179
Princeton 179
Nanjing 164
Shenyang 155
Hebei 102
New York 101
Boardman 77
Helsinki 74
Sindelfingen 70
Zhengzhou 65
Tianjin 59
Verona 59
Haikou 56
Seattle 56
Hangzhou 55
Taizhou 54
Nanchang 52
Changsha 51
Jiaxing 48
Dong Ket 45
Philadelphia 45
Ningbo 44
Falls Church 41
Milan 40
Fairfield 39
Guangzhou 36
Cambridge 35
Brussels 34
Taiyuan 31
Norwalk 30
Lanzhou 26
Rome 25
Dearborn 24
Lancaster 24
Fuzhou 23
Redwood City 22
Redmond 21
Seoul 20
Bologna 17
Auburn Hills 16
Provo 16
Düsseldorf 15
Washington 15
Los Angeles 12
Leawood 10
San Francisco 10
São Paulo 8
Grafing 7
Kochi 7
Kumasi 7
Zanjan 7
Ardabil 6
Brno 6
Catania 6
Hong Kong 6
Kemerovo 6
Munich 6
San Diego 6
Tappahannock 6
Torino 6
Toronto 6
Catanzaro 5
Clearwater 5
Parsa 5
Addis Ababa 4
Andover 4
Arezzo 4
Canberra 4
Chicago 4
Dalmine 4
Dresden 4
Frankfurt am Main 4
Fremont 4
Genoa 4
Genova 4
Groningen 4
Hefei 4
Montréal 4
Negrar 4
Orsogna 4
Paris 4
Patiāla 4
Ravenna 4
Riva 4
San Mateo 4
Turin 4
Vigasio 4
Ankara 3
Dallas 3
Totale 10.179
Salva come PNG Salva come JPEG
Nome #
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 311
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 147
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 136
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 128
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 126
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia 122
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 120
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 120
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 115
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 115
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 114
[Clinical and pathological staging of 85 patients with Hodgkin's disease: a clinical contribution (author's transl)] 114
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases] 113
An unusual case of acute leukaemia 112
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 112
Anemie iporigenerative ipercromiche e macrocitiche 112
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 110
Linfomi del tessuto linfatico associato alle mucose (MALT) delle ghiandole salivari. Descrizione di un caso in un paziente con infezione da virus C dell'epatite e revisione della letteratura 109
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 109
Unicentric Castleman's lymphadenopathy presenting with Behcet's syndrome: a case report 107
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases 106
Leucemie 106
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 105
Folic acid binding protein in chronic granulocytic leukaemia: the effect of methotrexate 104
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 104
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 104
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 103
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 102
Acute leukemia and pregnancy. Case report 101
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease 101
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 101
[Liver and spleen involvement in Hodgkin's disease: critical evaluation of diagnostic procedures (author's transl)] 100
Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML 99
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 99
Valutazione del significato della cupremia come indice di attività e come segno precoce di ricaduta nel cancro della mammella e nel morbo di Hodgkin (studio su 270 Casi). 99
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 98
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 97
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma 97
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 97
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 97
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 97
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 96
Terminal transferase expression in relapsed acute myeloid leukaemia 96
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 96
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma [see comments] 95
Mycobacterial infections preceding hairy-cell leukemia diagnosis. Description of two cases 94
Bone marrow transplantation monitoring by DNA analysis 94
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 94
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 94
Pilot study of survival of patients with chronic myeloid leukemia after determination of intracellular folate binding protein (FABP) 93
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 93
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency 93
Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. 92
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 91
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction 91
Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia 90
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 90
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia 89
Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions 89
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-a. 89
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha 89
CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases 89
Regulation of the proliferative potential of cord blood long term culture initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement 88
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 88
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 88
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. 87
Origin of the soluble interleukin 2 receptor in the serum of patients with hairy cell leukemia 87
Remission of severe antiphospholipid syndrome associated with non Hodgkin's B-cell lymphoma after combined treatment with Rituximab and chemotherapy 87
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 85
Patterns of outcome and prognostic factors in primary large cell lymphoma of the testis in a survey of 373 patients by the International Extranodal Lymphoma Study Grfoup (IELSG). 84
OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV 84
the International Extranodal Lymphoma Study group (IELSG). Intravascular lymphoma: clinical presentation, natural history, management, and prognostic factors in a series of 38 cases, with special emphasis on the “cutaneous variant”. 83
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 83
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 83
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 83
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 83
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 83
An assessment of chimeric transcript detection in CML patients after bone marrow transplantation 82
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 82
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 81
Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. 80
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 80
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 80
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis. 79
Specific and non specific folate binding protein in normal and malignant human tissues. 79
Treatment of elderly Hodgkin's lymphoma patients. The experience of the Italian Lymphoma Intergroup 79
Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy 79
Serum levels of soluble CD30 improve international prognostic score in predicting the outcome of advanced Hodgkin's lymphoma 79
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. 79
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol 79
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 79
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis 79
The role of autotransplantation in chronic lymphocytic leukemia and results from the italian group 78
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia 77
Stable hematological, cytogenetic and molecular remission in a splenectomised CML patient 22 years after diagnosis: analysis of cytokine production by PBMC subpopulations 77
Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined therapy with rutiximab and chemotherapy 77
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 77
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 77
High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas. 76
CT IMAGING OF PRIMARY PANCREATIC LYMPHOMA 76
Totale 9.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.775
article - articoli 31.648
book - libri 0
conference - conferenze 5.787
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.340
Totale 77.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019208 0 0 0 0 0 0 0 0 0 39 45 124
2019/20202.020 238 41 30 158 145 281 176 182 117 193 79 380
2020/20211.898 144 284 119 205 163 247 21 138 147 25 265 140
2021/20221.494 144 426 15 113 86 45 33 92 59 39 134 308
2022/20232.990 229 282 292 549 311 705 47 155 314 25 62 19
2023/20241.117 69 143 131 176 157 202 59 104 17 59 0 0
Totale 14.464